NASDAQ: NGNE 31.15%
Neurogene Shares Rally on FDA Breakthrough Therapy Designation for Rett Syndrome Therapy
NASDAQ: VEEA 30.24%
Veea Shares Surge After Launch of TerraFabric Edge Computing Platform
NASDAQ: PRAA 32.17%
PRA Group (PRAA) Q4 2025 Earnings Call Transcript
NYSE: KORE 77.39%
KORE Reports Third Quarter 2025 Results
NASDAQ: CDIO 32.65%
BioMedNewsBreaks - Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO) Schedules Investor Conference Call for Feb. 19, 2026
OTC: ACXIF 21.95%
Underperform Recommendation Issued On ACXIF By RBC Capital
OTC: NGNE 30.24%
OTC: VEEA 30.24%
OTC: PRAA 30.24%
OTC: KORE 30.24%
OTC: CDIO 30.24%
